Welcome to our dedicated page for Baxter Intl news (Ticker: BAX), a resource for investors and traders seeking the latest updates and insights on Baxter Intl stock.
Baxter International Inc. (NYSE: BAX) is a global medtech company whose news flow reflects its focus on connected care technologies, medical devices and advanced injectable therapies. On this page, readers can follow company announcements that illustrate how Baxter’s products and partnerships intersect with hospital operations, nursing workflows and patient safety.
Recent Baxter news highlights the launch of the Dynamo Series smart stretcher, designed for emergency departments, perioperative environments and patient transport services. Baxter reports that the Dynamo Series is intended to reduce the need for patient transfers, support a range of procedures in-stretcher, and incorporate technologies such as SafeView+ visual cues, bed exit alarms and optional connectivity to EMRs and nurse call systems to help prevent patient falls and support care teams.
Other updates include a multi-year strategic partnership with MUSC Health focused on integrating connected care technologies at the bedside. Baxter and MUSC Health describe objectives such as standardizing and simplifying bedside technologies, reducing documentation time, streamlining communication, improving nurse satisfaction and retention, and using real-time insights and advanced monitoring to enhance quality and safety outcomes.
Baxter also issues news on its infusion therapy portfolio, such as real-world data presented with The University of Texas Medical Branch on the Spectrum IQ large volume infusion pumps. These analyses examine how smart pump integration with electronic medical records may affect patient safety alerts, infusion programming time and clinician workload.
In addition, investors can find announcements on capital allocation decisions, including tender offers for senior notes, new note issuances and dividend declarations, as well as philanthropic news from the Baxter Foundation, such as grants to support STEM education through the Baxter Center for Science Education. Bookmark this page to access Baxter’s latest product, partnership, financial and community impact news in one place.
Baxter International (NYSE:BAX) has received FDA 510(k) clearance for its new Novum IQ syringe infusion pump, which features Dose IQ
Baxter International Inc. (NYSE:BAX) will present at the 2022 Wells Fargo Healthcare Conference on September 7, 2022, at 10:25 a.m. Eastern Time. CFO Jay Saccaro is scheduled to discuss the company’s innovations and healthcare solutions. A live webcast of the presentation can be accessed at www.baxter.com and will be available for replay until February 23, 2023. Baxter has a 90-year history of providing critical healthcare products and services globally, impacting millions of patients and caregivers.
Baxter International Inc. (NYSE:BAX) will participate in the Morgan Stanley 20th Annual Global Healthcare Conference on September 14, 2022. Jay Saccaro, Chief Financial Officer, is set to present at 10:35 a.m. Eastern Time. A live webcast of the presentation will be available on Baxter's website and can be replayed until March 13, 2023. Baxter has a long-standing history of providing essential medical products and innovations that improve healthcare across more than 100 countries.
Summary not available.
Baxter International Inc. (NYSE:BAX) reported second-quarter 2022 revenue of $3.75 billion, marking a 21% increase on a reported basis and a 26% increase on a constant currency basis. U.S. GAAP EPS was $0.50, with adjusted EPS at $0.87. The company anticipates full-year sales growth in the high teens and forecasts U.S. GAAP EPS between $1.82 and $1.92. Despite operational challenges, including supply chain issues, Baxter's acquisition of Hillrom contributed significantly to performance, generating $715 million in sales.
Baxter International Inc. (NYSE:BAX) has declared a quarterly cash dividend of $0.29 per share, payable on October 3, 2022, to shareholders on record as of September 2, 2022. This brings the indicated annual dividend rate to $1.16 per share. Baxter, a leader in medical technology, provides critical care and innovative healthcare solutions globally, with a mission to save and sustain lives. The company emphasizes its commitment to shareholder value through consistent dividend payments, though future payouts may vary based on financial conditions.
Summary not available.
Baxter International Inc. (NYSE:BAX) will host a conference call on July 28, 2022, at 7:30 a.m. CT to discuss its second-quarter financial results. Interested participants can join the call via a pre-registration link or through Baxter's website. The call will be recorded and is copyrighted material.
Baxter has been a leader in medtech for 90 years, providing essential products and solutions across various care settings globally, impacting millions of patients and caregivers daily. For more information, visit www.baxter.com.
Baxter International Inc. (NYSE:BAX) is set to present at the Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022, at 10:40 a.m. Pacific Time. José Almeida, the company’s CEO, will lead the presentation. The event will feature a live webcast, accessible at www.baxter.com, with replay available until June 13, 2023. Baxter continues to deliver critical healthcare solutions globally, enhancing patient care for nearly a century.
Baxter International (NYSE:BAX) hosted its 2022 Investor Conference, outlining its strategy for growth and innovation following the Dec. 2021 acquisition of Hillrom. The company aims to enhance patient care and operational efficiency, expecting constant currency sales growth of 4-5% from 2022-2025, with a projected adjusted operating margin increase of 350-400 basis points by 2025. Baxter anticipates $350 million in annual cost synergies and $200 million in revenue synergies by 2025 from the acquisition. Innovations showcased include the Sharesource platform and Voalte communication technologies.